Nigel Ten Fleming
Vorstandsvorsitzender bei Minerva Healthcare, Inc.
Aktive Positionen von Nigel Ten Fleming
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Minerva Healthcare, Inc. | Vorstandsvorsitzender | 01.01.2008 | - |
| Vorsitzender | 01.01.2008 | - | |
G2B Pharma, Inc.
 G2B Pharma, Inc. Pharmaceuticals: MajorHealth Technology G2B Pharma, Inc. focuses on the development of nasally delivered drugs, including nasally delivered epinephrine for the treatment of anaphylaxis. Its product anaphylaxis, a severe and life-threatening allergic reaction that can include rash, swelling of the tongue and throat, and a sudden drop in blood pressure. The company was founded by Nigel Ten Fleming and Mike Doodson and is headquartered in Corte Madera, CA. | Vorstandsvorsitzender | - | - |
| Gründer | - | - | |
| Vorsitzender | - | - | |
| Adventura Capital SL | Vorstandsvorsitzender | - | - |
| Gründer | - | - |
Karriereverlauf von Nigel Ten Fleming
Ehemalige bekannte Positionen von Nigel Ten Fleming
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Serenus Biotherapeutics, Inc.
 Serenus Biotherapeutics, Inc. Medical DistributorsDistribution Services Serenus Biotherapeutics, Inc. distributes and manufactures pharmaceutical drug products. The company is headquartered in San Francisco, CA. | Direktor/Vorstandsmitglied | 01.05.2014 | 01.08.2016 |
Impax Laboratories LLC
 Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Impax Laboratories LLC operates as a technology based specialty pharmaceutical company. It engages in the development, manufacture, and marketing of controlled-release and niche generics. The company was founded on December 14, 1999 and is headquartered in Bridgewater, NJ. | Direktor/Vorstandsmitglied | 14.12.1999 | 17.05.2016 |
| Independent Dir/Board Member | 14.12.1999 | 17.05.2016 | |
Minoryx Therapeutics SL
 Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Vorsitzender | 01.01.2011 | 27.01.2016 |
| Gründer | 01.01.2011 | 27.01.2016 | |
Genmedica Therapeutics SL
 Genmedica Therapeutics SL BiotechnologyHealth Technology Genmedica Therapeutics SL engages in the research and development of new treatments for diabetes. Its has developed novel NCE-generating platform to generate dual action, small molecules that act against oxidative stress and inflammation, two specific pathways known to be critical in the root causes of the disease. The company was founded by Alec Humayun Mian and Luc Marti Clauzel on June 21, 2004 and is headquartered in Barcelona, Spain. | Direktor/Vorstandsmitglied | 22.03.2010 | - |
| Examplar | Direktor/Vorstandsmitglied | 01.01.1992 | - |
A-CUBE, Inc.
 A-CUBE, Inc. BiotechnologyHealth Technology A-CUBE, Inc. develops novel antibodies. It utilizes silico algorithms and to discover novel druggable targets suitable for developing human therapeutic interventions, including next generation drugs for commercially proven targets. The company was founded by Nobuyuki Ota is headquartered in Belmont, CA. | Vorsitzender | 01.09.2011 | - |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
| ░░░░░░░░ | - | - | |
| ░░░░░░░ | - | - | |
| ░░░░ ░░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░ ░░░░ ░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Nigel Ten Fleming
| University of Cambridge | Doctorate Degree |
| The University of North Carolina at Chapel Hill | Undergraduate Degree |
| Boston University School of Medicine | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 16 |
| Spanien | 4 |
| Vereinigtes Königreich | 2 |
Operativ
| Chief Executive Officer | 6 |
| Founder | 6 |
| Director/Board Member | 5 |
Sektoral
| Health Technology | 8 |
| Commercial Services | 5 |
| Consumer Services | 5 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
Athena Neurosciences LLC
 Athena Neurosciences LLC Miscellaneous Commercial ServicesCommercial Services Athena Neurosciences LLC operates as a research-based pharmaceutical company committed to the field of neurology. It develops therapeutic and diagnostic products. The company was founded by David Rowley-Jones, Larry C. Fritz, and Larry A. Bock in 1986 and is headquartered in Allegan, MI. | Commercial Services |
Impax Laboratories LLC
Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Impax Laboratories LLC operates as a technology based specialty pharmaceutical company. It engages in the development, manufacture, and marketing of controlled-release and niche generics. The company was founded on December 14, 1999 and is headquartered in Bridgewater, NJ. | Health Technology |
Blueprint Genetics, Inc.
 Blueprint Genetics, Inc. Miscellaneous Commercial ServicesCommercial Services Athena Diagnostics, Inc. provides clinical diagnostics testing laboratory services. The firm focuses on neurology, endocrinology, hearing loss and nephrology. It offers tests for Alzheimer's disease, muscular dystrophy and other neuromuscular and developmental disorders. The company was founded in 1988 and is headquartered in Marlborough, MA. | Commercial Services |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Health Technology |
BioVision, Inc.
 BioVision, Inc. Pharmaceuticals: MajorHealth Technology BioVision, Inc. manufactures pharmaceutical products for apoptosis and cell signaling. It offers assay kits, antibodies, and recombinant proteins and enzymes. The company is headquartered in Milpitas, CA. | Health Technology |
| Genica Pharmaceuticals Corp. | Commercial Services |
| Minerva Healthcare, Inc. | |
| Examplar | |
Genmedica Therapeutics SL
Genmedica Therapeutics SL BiotechnologyHealth Technology Genmedica Therapeutics SL engages in the research and development of new treatments for diabetes. Its has developed novel NCE-generating platform to generate dual action, small molecules that act against oxidative stress and inflammation, two specific pathways known to be critical in the root causes of the disease. The company was founded by Alec Humayun Mian and Luc Marti Clauzel on June 21, 2004 and is headquartered in Barcelona, Spain. | Health Technology |
| PATH Drug Solutions | Commercial Services |
A-CUBE, Inc.
A-CUBE, Inc. BiotechnologyHealth Technology A-CUBE, Inc. develops novel antibodies. It utilizes silico algorithms and to discover novel druggable targets suitable for developing human therapeutic interventions, including next generation drugs for commercially proven targets. The company was founded by Nobuyuki Ota is headquartered in Belmont, CA. | Health Technology |
G2B Pharma, Inc.
G2B Pharma, Inc. Pharmaceuticals: MajorHealth Technology G2B Pharma, Inc. focuses on the development of nasally delivered drugs, including nasally delivered epinephrine for the treatment of anaphylaxis. Its product anaphylaxis, a severe and life-threatening allergic reaction that can include rash, swelling of the tongue and throat, and a sudden drop in blood pressure. The company was founded by Nigel Ten Fleming and Mike Doodson and is headquartered in Corte Madera, CA. | Health Technology |
Minoryx Therapeutics SL
Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Health Technology |
| Adventura Capital SL | |
Serenus Biotherapeutics, Inc.
Serenus Biotherapeutics, Inc. Medical DistributorsDistribution Services Serenus Biotherapeutics, Inc. distributes and manufactures pharmaceutical drug products. The company is headquartered in San Francisco, CA. | Distribution Services |
- Börse
- Insiders
- Nigel Ten Fleming
- Erfahrung